News | April 06, 2015

SCAI 2015 Opening Session to Highlight Disruptive Technologies in Cardiovascular Care

Drs. Peter Fitzgerald and Christian Assad-Kottner will examine impacts of rising costs, variability in care and encourage physicians to embrace change

April 6, 2015 — The opening session speakers at the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions will examine the current state of cardiovascular care and why it is ripe for disruption and new technologies. Peter Fitzgerald, M.D., Ph.D., of Stanford University, and Christian Assad-Kottner, M.D., of the Fogarty Institute for Innovation and El Camino Hospital in Mountain View, California, will explore how increasing costs and variability in healthcare provide the potential to change how cardiovascular care is provided. SCAI 2015 will be held in San Diego May 6-9.

“Variability in care, health system consolidation and increasing financial pressures are driving an increasing need for standardization,” said Fitzgerald. “At the same time, innovative companies like Apple, Google and Samsung are entering healthcare. This convergence will drive greater change in how interventional cardiologists provide care, and it’s something we can all embrace.”

In his presentation, Fitzgerald will share examples of how emerging technologies will lead to better care. “Incredible point-of-care diagnostics are available today,” he said. “Soon we’ll be able to model the size and length of stent needed before we get to the cath lab. And we’ll be able to better assess the patient’s outcomes – that’s exciting because we can provide even better care, more efficiently and possibly for more patients.”

Interventional cardiologists will also need to understand and use new exponential technologies, which are types of technologies that rapidly evolve even as they fundamentally change medicine, according to Assad-Kottner. Examples include 3-D printing, robotics, genomics, sensors and artificial intelligence. Physicians are just beginning to understand and evaluate how these and other technologies can impact patient care.

“We have the ability to take our medical knowledge and use new technologies to creatively solve the problems we face today,” said Assad-Kottner.

Already, young physicians are beginning not only to embrace these changes but also to demand them, said Fitzgerald. As medical schools broaden their focus to include business, healthcare economics and information technology, young physicians are entering the field better prepared for the changes that are ahead.

“The students are demanding the change,” said Fitzgerald. “Our 30-year-olds are emerging from medical schools with so much more in their armamentarium. Still, there’s a lot of wisdom experienced interventional cardiologists can share to improve these new systems. We all need to get involved because it’s an exciting time for the field of interventional cardiology.”

For more information:

Related Content

Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott While Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Overlay Init